Feasibility of a Hybrid Risk-Adapted Monitoring System in Investigator-Sponsored Trials in Cancer.

Sinae KimYunJung KimYoungLan HongYunOk KimJoon Seo LimJiSung LeeTae Won Kim

Published in: Therapeutic innovation & regulatory science (2020)

Our hybrid monitoring system showed acceptable feasibility in revealing both major and minor issues in multi-center oncology investigator-sponsored trials.

Keyphrases

papillary thyroid
palliative care
squamous cell carcinoma
young adults
childhood cancer